Review of HIV-1 protease inhibitor assay methods

Current Pharmaceutical Analysis

Volumn 3, Issue 3, 2007, Pages 180-185

  Hur, Duik ^a   DiFrancesco, Robin ^a   Hochreiter, Jill ^a   Ma, Qing ^a   Slish, Judianne ^a   Maponga, Chiedza C ^a,b   Morse, Gene D ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

High performance liquid chromatography; Indinavir; Nucleoside and nonnucleoside reverse; Protein precipitation; Therapeutic drug monitoring; Transcriptase inhibitors

Indexed keywords

AG 1402; AMPRENAVIR; AMPRENAVIR PHOSPHATE; ANTIRETROVIRUS AGENT; ATAZANAVIR; INDINAVIR; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; TIPRANAVIR; UNCLASSIFIED DRUG;

DRUG ABSORPTION; DRUG DETERMINATION; DRUG DOSE REGIMEN; DRUG MONITORING; DRUG SOLUBILITY; DRUG STRUCTURE; EMBASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS 1; LIQUID LIQUID EXTRACTION; MEDLINE; MOLECULAR WEIGHT; PKA; PRECIPITATION; PRIORITY JOURNAL; REVIEW; SOLID PHASE EXTRACTION; SPECTROPHOTOMETER; TANDEM MASS SPECTROMETRY; VIRUS RESISTANCE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34548306417     PISSN: 15734129     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341207781369321     Document Type: Review

References (53)

1. Deeks, S. G.; Volberding, P. A. AIDS Clin. Rev., 1997, 145.
2. Ho, D. D. N. Engl. J. Med., 1995, 333, 450.
3. Burger, D.; Boyd, M.; Duncombe, C.; Felderhof, M.; Mahanontharit, A.; Ruxrungtham, K.; Ubolyam, S.; Stek, M.; Cooper, D.; Lange, J.; Phanupak, P.; Reiss, P. J. Antimicrob. Chemother., 2003, 51, 1231.
4. Burger, D.M.; Bergshoeff, A.S.; De Groot, R.; Gibb, D.; Walker, S.; Treluyer, J. M.; Hoetelmans, R. M. J. Pediatr., 2004, 145, 403.
5. Burger, D.M.; Hoetelmans, R.M.; Hugen, P.W.; Mulder, J.W.; Meenhorst, P.L.; Koopmans, P.P.; Brinkman, K.; Keuter, M.; Dolmans, W.; Hekster, Y. A. Antivir. Ther., 1998, 3, 215.
6. Burger, D.; Hugen, P.; Reiss, P.; Gyssens, I.; Schneider, M.; Kroon, F.; Schreij, G.; Brinkman, K.; Richter, C.; Prins, J.; Aarnoutse, R.; Lange, J. Aids, 2003, 17, 1157.
7. Gerber, J. G.; Acosta, E. P. J. Clin. Virol., 2003, 27, 117.
8. Back, D.; Gatti, G.; Fletcher, C.; Garaffo, R.; Haubrich, R.; Hoetelmans, R.; Kurowski, M.; Luber, A.; Merry, C.; Perno, C. F. Aids, 2002, 16 (Suppl 1), S5.
9. Back, D.G.; G.; Fletcher, C. Goroffo, R.; Haubrich, R.; Hoetelmans, R.; Kurowski, M.; Luber, A.; Merry, C.; Perno, C. AIDS, 2002, 16, S5.
10. Flexner, C. W. Top HIV Med., 2003, 11, 40.
11. Merry, C.; Barry, M. G.; Mulcahy, F.; Tjia, J. F.; Halifax, K. L.; Heavey, J.; Kelly, C.; Back, D. J. Aids, 1998, 12, 325.
12. Kamdem, L. K.; Streit, F.; Zanger, U. M.; Brockmoller, J.; Oellerich, M.; Armstrong, V. W.; Wojnowski, L. Clin. Chem., 2005, 51, 1374.
13. Merry, C.; Barry, M. G.; Mulcahy, F.; Ryan, M.; Heavey, J.; Tjia, J. F.; Gibbons, S. E.; Breckenridge, A. M.; Back, D. J. Aids, 1997, 11, F29.
14. Invirase (Saquinavir) Product Information. Roche: Nutley, NJ. http://www.rocheusa.com/products/invirase/ (accessed March 2007).
15. Reyataz (Atazanavir) Product Information. Bristol-Myers Squibb Company: Princeton, NJ, www.reyataz.com/ (accessed March 2007).
16. Catanzaro, L.; Slish, J.; DiCenzo, R.; Morse, GD. Current HIV/AIDS Reports, 2004, 1, 89.
17. Morse, G. D.; Catanzaro, L. M.; Acosta, E. P. Lancet Infect. Dis., 2006, 6, 215.
18. Frerichs Valerie A., D. R., Morse Gene D. J. Chromatogr. B, 2003, 787, 393.
19. Titier, K.; Lagrange, F.; Pehourcq, F.; Edno-Mcheik, L.; Moore, N.; Molimard, M. Ther. Drug Monit., 2002, 24, 417.
20. Ucpinar, S. D.; Stavchansky, S. Biomed. Chromatogr., 2003, 17, 21.
21. Dailly, E.; Reliquet, V.; Victorri-Vigneau, C.; Raffi, F.; Jolliet, P. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2006, 832, 317.
22. Panchagnula, R.; Bansal, T.; Varma, M.V.; Kaul, C.L. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2004, 806, 277.
23. Chi, J.; Jayewardene, A.L.; Stone, J.A.; Motoya, T.; Aweeka, F.T. J. Pharm. Biomed. Anal., 2002, 30, 675.
24. Rouzès, A.; Berthoin, K.; Xuereb, F.; Djabarouti, S.; Pellegrin, I.; Pellegrin, J.L.; Coupet, A.C.; Augagneur, S.; Budzinski, H.; Saux, M. C.; Breilh, D. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2004, 813, 209.
25. Notari, S.; Bocedi, A.; Ippolito, G.; Narciso, P.; Pucillo, L, P.; Tossini, G.; Donnorso, R. P.; Gasparrini, F., Ascenzi, P. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2006, 831, 258.
26. Dickinson, L.; Robinson, L.; Tjia, J.; Khoo, S.; Back, D. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2005, 829, 82.
27. Colombo, S.; Beguin, A.; Telenti, A.; Biollaz, J.; Buclin, T.; Rochat, B.; Decosterd, L.A. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2005, 819, 259.
28. Rezk, N.L.; Tidwell, R.R.; Kashuba, A.D. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2004, 805, 241.
29. Justesen, U.S.; Pedersen. C.; Klitgaard, N.A. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2003, 783, 491.
30. Poirier, J.M.; Robidou, P.; Jaillon, P. Ther. Drug Monit., 2002, 24, 302.
31. Rentsch, K.M. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2003, 788, 339.
32. Villani, P.; Feroggio, M.; Gianelli, L.; Bartoli, A.; Montagna, M.; Maserati, R.; Regazzi, M.B. Ther. Drug Monit., 2001, 23, 380.
33. Droste, J.A.; Verweij-Van Wissen, C.P.; Burger, D.M. Ther. Drug Monit., 2003, 25, 393.
34. Giraud, E.; Rey, E.; Treluyer, J. M.; Pons, G.; Jullien, V. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2006, 830, 86.
35. Loregian, A.; Pagni, S.; Ballarin, E.; Sinigalia, E.; Parisi, S. G.; Palu, G. J. Pharm. Biomed. Anal., 2006, 42, 500.
36. Schuster, A.; Burzawa. S.; Jemal, M.; Loizillon, E.; Couerbe, P.; Whigan, D. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2003, 788, 377.
37. Hirabayashi, Y.; Tsuchiya, K.; Kimura, S.; Oka, S. Biomed. Chromatogr., 2006, 20, 28.
38. Usami, Y.; Oki, T.; Nakai, M.; Sagisaka, M.; Kaneda, T. Chem. Pharm. Bull (Tokyo), 2003, 51, 715.
39. Crommentuyn, K. M.; Rosing, H.; Nan-Offeringa, L. G.; Hillebrand, M.J.; Huitema, A.D.; Beijnen, J.H. J. Mass Spectrom., 2003, 38, 157.
40. Ray, J.; Pang, E.; Carey, D. J. Chromatogr. B Analyt. Technol Biomed Life Sci., 2002, 775, 225.
41. Tribut, O.; Arvieux, C.; Michelet, C.; Chapplain, J. M.; Allain, H.; Bentue-Ferrer, D. Ther. Drug Monit., 2002, 24, 554.
42. Turner, M.L.; R.-W.K., King, J.R.; Acosta, EP. J. Chromatogr. B, 2003, 784, 331.
43. Estelle Cateau, N.T.; Antoine, D.; Gwenaël Le, M.; Nicolas, V. J. Pharm. Biomed. Anal., 2005, 39, 791.
44. Dailly, E.; Raffi, F.; Jolliet, P. J. Chromatog. B Analyt. Technol. Biomed. Life Sci., 2004, 813, 353.
45. Marzolini, C.; Beguin, A.; Telenti, A.; Schreyer, A.; Buclin, T.; Biollaz, J.; Decosterd, L.A. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci., 2002, 774, 127.
46. Keil, K.; Frerichs, V. A.; DiFrancesco, R.; Morse, GD. Ther. Drug Monit., 2003, 25, 340.
47. Koal, T.S.M.; Koster, E.; Reach, K.; Kaever, V. Clin. Chem. Lab. Med., 2006, 44, 299.
48. Takahashi, M.Y.M.; Oki, T.; Okumura, N.; Suzuki, T.; Kaneda, T. Biol. Pharm. Bull., 2005, 28, 1286.
49. Egge-Jacobsen, W.; Unger, M.; Niemann, C. U.; Baluom, M.; Hirai, S.; Benet, L.Z.; Christians, U. Ther. Drug Monit., 2004, 26, 546.
50. Boffito, M.; Acosta, E.; Burger, D.; Fletcher, C.V.; Flexner, C.; Garaffo, R.; Gatti, G.; Kurowski, M.; Perno, C.F.; Peytavin, G.; Regazzi, M.; Back, D. Antivir. Ther., 2005, 10, 375.
51. Boffito, M.; Maitland, D.; Samarasinghe, Y.; Pozniak, A. Curr. Opin. Infect Dis., 2005, 18, 1.
52. Boffito, M.; Acosta, E.; Burger, D.; Fletcher, C.V.; Flexner, C.; Garaffo, R.; Gatti, G.; Kurowski, M.; Perno, C.F.; Peytavin, G.; Regazzi, M.; Back, D. Antivir. Ther., 2005, 10, 469.
53. Maponga, C.C. M.Q.; Slish, J.; Morse, G.D. Topics in HIV Medicine, 2007 (In press).